1. Evaluation of contrast markers for CT aspiration biopsy
- Author
-
Nadaraja N, Balaji Mr, Roth-Moyo L, Mehnert Pj, Boger Jn, Marx Aj, and Stephenson Tf
- Subjects
Male ,medicine.medical_specialty ,Percutaneous ,Esophageal Neoplasms ,Lymphoma ,media_common.quotation_subject ,Contrast Media ,Computed tomography ,Biopsy Site ,Stomach Neoplasms ,Aspiration biopsy ,Biopsy ,Humans ,Medicine ,Contrast (vision) ,Radiology, Nuclear Medicine and imaging ,Biopsy procedure ,Aged ,Pelvic Neoplasms ,media_common ,medicine.diagnostic_test ,business.industry ,Biopsy, Needle ,General Medicine ,Middle Aged ,Staining ,Evaluation Studies as Topic ,Carcinoma, Squamous Cell ,Radiology ,Tomography, X-Ray Computed ,business - Abstract
Precision percutaneous needle aspiration biopsy under guidance of computed tomography is facilitated by injection of a small amount of contrast material during the biopsy procedure. CT scan immediately after biopsy clearly documents the biopsy site. There was no adverse effect of the contrast agents on the quality of staining or preservation of cellular architecture. To the contrary, the aspirates obtained after contrast injection were generally better preserved and better stained than the control specimens. This may be due to a decrease in drying, with the more fluid aspirates obtained after contrast injection.
- Published
- 1979
- Full Text
- View/download PDF